Cargando…

Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study

BACKGROUND/AIM: Ankaferd hemostat (ABS; Ankaferd blood stopper, İstanbul, Turkey) is a prohemostatic agent affecting erythrocytes. The hemostatic action of ABS depends upon fibrinogen gamma chain, prothrombin, and red blood cells. The aim of this study was to assess the effects of ABS on erythrocyte...

Descripción completa

Detalles Bibliográficos
Autores principales:	ÇİFTÇİLER, Rafiye, AKSU, Salih, DİKMENOĞLU FALKMARKEN, Neslihan, HAZNEDAROĞLU, Ibrahim Celalettin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350838/ https://www.ncbi.nlm.nih.gov/pubmed/30761848 http://dx.doi.org/10.3906/sag-1808-60

Ejemplares similares

Ankaferd hemostat: from molecules to medicine
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2020)

Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)
por: Ciftciler, Rafiye, et al.
Publicado: (2020)

Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2019)

Antineoplastic Effects of Ankaferd Hemostat
por: Malkan, Umit Yavuz, et al.
Publicado: (2022)

Antiinfective and wound-healing pleiotropic actions of Ankaferd hemostat
por: HAZNEDAROĞLU, İbrahim Celalettin, et al.
Publicado: (2020)

Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines
por: Turk, Seyhan, et al.
Publicado: (2017)

Endothelial Cells, Ankaferd Hemostat, and Estradiol
por: Ardıçoğlu, Yasemin, et al.
Publicado: (2016)

Pathobiological Interactions of Local Bone Marrow Renin-Angiotensin System and Central Nervous System in Systemic Arterial Hypertension
por: Ciftciler, Rafiye, et al.
Publicado: (2020)

The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine
por: Okay, Mufide, et al.
Publicado: (2019)

The Factors Affecting Early Death in Newly Diagnosed APL Patients
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation
por: Çiftçiler, Rafiye, et al.
Publicado: (2021)

A New Candidate as a Hemostatic Agent for Difficult Situations During Variceal Bleeding: Ankaferd Blood Stopper
por: Ozaslan, Ersan, et al.
Publicado: (2011)

Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids
por: Koluman, Ahmet, et al.
Publicado: (2016)

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
por: Çiftçiler, Rafiye, et al.
Publicado: (2019)

Effect of the plant-based hemostatic agent Ankaferd Blood Stopper® on the biocompatibility of mineral trioxide aggregate
por: Dinçol, Muzaffer Emir, et al.
Publicado: (2016)

Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach
por: Koçak, Engin, et al.
Publicado: (2019)

Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases
por: Koluman, Ahmet, et al.
Publicado: (2017)

On Being a “Physician Patient” with His Own Experimental Therapeutic Drug
por: Çiftçiler, Rafiye, et al.
Publicado: (2018)

COVID-19, Renin-Angiotensin System, and Hematopoiesis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
por: OKAY, Müfide, et al.
Publicado: (2019)

Oral High-Dose Ankaferd Administration Effects on Gastrointestinal System
por: Akbal, Erdem, et al.
Publicado: (2013)

Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper
por: Simsek, Cem, et al.
Publicado: (2017)

Comparison of bortezomibcyclophosphamide- dexamethasone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients
por: Ciftciler, Rafiye, et al.
Publicado: (2020)

Indications and Outcomes of Splenectomy for Hematological Disorders
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content
por: Beyazit, Fatma, et al.
Publicado: (2020)

The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

In Vitro Efficacy of the Ankaferd Galenic Hemostatic Extract as a Germicidal Agent
por: METİN, Bayram, et al.
Publicado: (2016)

Generation of Chimeric “ABS Nanohemostat” Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model
por: Huri, Emre, et al.
Publicado: (2013)

Comparison of hemostatic efficacy of topical Ankaferd Blood Stopper on heparinized and nonheparinized rats in bleeding related to liver injury
por: Ergin, Metin, et al.
Publicado: (2021)

The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge
por: Karabıyık, Afife, et al.
Publicado: (2012)

Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, ankaferd blood stopper, on vascular tissue in a rat aortic bleeding model
por: Kandemir, Ozer, et al.
Publicado: (2010)

The Effectiveness of a New Hemostatic Agent (Ankaferd Blood Stopper) for the Control of Bleeding following Tooth Extraction in Hemophilia: A Controlled Clinical Trial
por: Kazancıoğlu, Hakkı Oğuz, et al.
Publicado: (2013)

Effect of ankaferd blood stopper in experimental peritoneal adhesion model
por: Karaca, Gokhan, et al.
Publicado: (2016)

Experimental Investigation of the Effects of a Blood Stopper Agent (Ankaferd Blood Stopper) on Bone Surfaces
por: Şimşek, Hasan Onur, et al.
Publicado: (2013)

Spontaneous subepithelial hemorrhage of renal pelvis and ureter (Antopol-Goldman lesion) in hemophilia A patient with inhibitor: Case report and review of the literature
por: Sahin, Taha Koray, et al.
Publicado: (2020)

Analysing the blood-stemming effect of Ankaferd Blood Stopper in medulla spinalis surgery
por: TÜRKÖZ, Dursun, et al.
Publicado: (2020)

Effects of C-peptide on Microvascular Blood Flow and Blood Hemorheology
por: Forst, T., et al.
Publicado: (2004)

The effect of Ankaferd blood stopper on liver damage in experimental obstructive jaundice
por: KOŞMAZ, Koray, et al.
Publicado: (2021)

Does endurance training improve red blood cell aging and hemorheology in moderate-trained healthy individuals?
por: Bizjak, Daniel A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_apo4t1dsfp8l5gev6rfg38t2ja